EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Cardiovascular Aging

Marco Tana iD, Rachele Piccinini, Livia Moffa, Ettore Porreca, Fernando Tana, Claudio Tana

Reviews in Cardiovascular Medicine · 23.07.2025 · 26 (7)

DOI: 10.31083/rcm27437 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Reviews in Cardiovascular Medicine, online erschienen am 23.07.2025. Verfasst von Marco Tana und 5 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine and Cardiovascular Ultrasound Unit, Medical Department, SS. Annunziata Hospital, 66100 Chieti, Italy. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aging is a slow, progressive, and inevitable process that affects multiple organs and tissues, including the cardiovascular system. The most frequent cardiac and vascular alterations that are observed in older adults (especially patients aged ≥80 years) are diastolic and systolic dysfunction, progressive stiffening of the vascular wall and endothelial impairment usually driven by an excess of extracellular matrix (ECM) and profibrotic substances, reduced levels of matrix metalloproteinases (MMPs), or by amyloid and calcium deposits in myocardium and valves (especially in aortic valves). Moreover, deformation of the heart structure and shape, or increased adipose tissue and muscle atrophy, or altered ion homeostasis, chronotropic disability, reduced heart rate, and impaired atrial sinus node (SN) activity are other common findings. Interestingly, aging is often associated with oxidative stress, alterations in the mitochondrial structure and function, and a low-grade proinflammatory state, characterized by high concentrations of cytokines and inflammatory cells, without evidence of infectious pathogens, in a condition known as ‘inflammaging’. Aging is a well-recognized independent risk factor for cardiovascular disease and easily leads to high mortality, morbidity, and reduced quality of life. Recently, several efforts have been made to mitigate and delay these alterations, aiming to maintain overall health and longevity. The primary purpose of this review was to provide an accurate description of the underlying mechanisms while also exploring new therapeutic proposals for oxidative stress and inflammaging. Moreover, combining serum biomarkers with appropriate imaging tests can be an effective strategy to stratify and direct the most suitable treatment.

Schlagwörter

Stichwörter der Autor:innen

cardiac amyloidosiscardiovascular agingejection fractionheart failureoxidative stress

Autor:innen und Institutionen

  • Internal Medicine and Cardiovascular Ultrasound Unit, Medical Department, SS. Annunziata Hospital, 66100 Chieti, Italy.
  • School of Internal Medicine, G. D'Annunzio University, 66100 Chieti, Italy.
  • Oncology Unit, School of Medical Oncology, Polytechnic University of the Marche, 60121 Ancona, Italy.
  • Infectious Diseases Unit, School of Infectious Diseases, G. D'Annunzio University, 66100 Chieti, Italy.
  • AUSL Pescara, 65125 Pescara, Italy.
  • Geriatric Clinic, SS Annunziata Hospital, 66100 Chieti, Italy.

ORCID-Profile: Marco Tana

Zitieren

APA

Tana, M., Piccinini, R., Moffa, L., Porreca, E., Tana, F., & Tana, C. (2025). Cardiovascular Aging. Reviews in Cardiovascular Medicine, 26(7). https://doi.org/10.31083/rcm27437

Vancouver

Tana M, Piccinini R, Moffa L, Porreca E, Tana F, Tana C. Cardiovascular Aging. Reviews in Cardiovascular Medicine. 2025;26(7). doi:10.31083/rcm27437

BibTeX
@article{Tana2025,
  author = {Tana, Marco and Piccinini, Rachele and Moffa, Livia and Porreca, Ettore and Tana, Fernando and Tana, Claudio},
  title = {Cardiovascular Aging},
  journal = {Reviews in Cardiovascular Medicine},
  year = {2025},
  volume = {26},
  number = {7},
  doi = {10.31083/rcm27437}
}
Kostenlos starten →